Radiotherapy compliance is maintained with hyprofractionation and concurrent cetuximab in locally advanced head and neck cancer

被引：8

作者：

Chan, Andrew ^{[1
]}

Teoh, Daien ^{[1
]}

Singhera, Paul ^{[1
]}

Hartley, Andrew ^{[1
]}

机构：

[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England

来源：

RADIOTHERAPY AND ONCOLOGY | 2009年 / 93卷 / 03期

关键词：

SQUAMOUS-CELL CARCINOMA;

D O I：

10.1016/j.radonc.2009.05.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：654 / 654

页数：1

共 50 条

[31] Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab
Naoya Murakami
Seiichi Yoshimoto
Fumihiko Matsumoto
Takao Ueno
Yoshinori Ito
Satoru Watanabe
Kazuma Kobayashi
Ken Harada
Mayuka Kitaguchi
Shuhei Sekii
Kana Takahashi
Kotaro Yoshio
Koji Inaba
Madoka Morota
Minako Sumi
Yutaka Saito
Jun Itami
Journal of Cancer Research and Clinical Oncology, 2015, 141 : 177 - 184
[32] Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma A meta-analysis
Tang, Wen-Hua
Sun, Wei
Long, Guo-Xian
MEDICINE, 2020, 99 (36)
[33] Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab
Murakami, Naoya
Yoshimoto, Seiichi
Matsumoto, Fumihiko
Ueno, Takao
Ito, Yoshinori
Watanabe, Satoru
Kobayashi, Kazuma
Harada, Ken
Kitaguchi, Mayuka
Sekii, Shuhei
Takahashi, Kana
Yoshio, Kotaro
Inaba, Koji
Morota, Madoka
Sumi, Minako
Saito, Yutaka
Itami, Jun
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (01) : 177 - 184
[34] SEVERE GASTROINTESTINAL BLEEDING IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA TREATED BY CONCURRENT RADIOTHERAPY AND CETUXIMAB
Murakami, Naoya
Yoshimoto, Seiichi
Matsumoto, Fumihiko
Ueno, Takao
Ito, Yoshinori
Kobayashi, Kazuma
Harada, Ken
Kitaguchi, Mayuka
Sekiii, Shuhei
Takahashi, Kana
Yoshio, Kotaro
Inaba, Koji
Morota, Madoka
Sumi, Minako
Saito, Yutaka
Itami, Jun
ANTICANCER RESEARCH, 2014, 34 (10) : 6075 - 6075
[35] Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy
Valeriani, M.
Muni, R.
Osti, M. F.
De Sanctis, V.
Minniti, G.
Ardito, F.
Enrici, R. Maurizi
RADIOLOGIA MEDICA, 2012, 117 (01): : 125 - 132
[36] Concurrent Radiotherapy With Cetuximab or Platinum-based Chemotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
Lu, Sharon M.
Lien, Winston W.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (01): : 95 - 99
[37] Treatment Outcome of Cetuximab Compared with Cisplatin during Radical Radiotherapy for Locally Advanced Head and Neck Cancer
Law, K. S.
Wong, R. K. Y.
Yu, E.
Cheng, A. C. K.
HONG KONG JOURNAL OF RADIOLOGY, 2016, 19 (02): : 96 - 102
[38] COST-EFFECTIVENESS OF CETUXIMAB COMBINED WITH RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER IN TAIWAN
Chan, A. L.
Leung, H. W.
Lin, S. J.
VALUE IN HEALTH, 2010, 13 (03) : A40 - A40
[39] Concurrent Cetuximab Is Associated With Decreased Overall Survival In Patients With Locally Advanced Head And Neck Cancer Receiving Definitive Radiotherapy: A National Cancer Database Analysis
Korpics, M. C.
Koshy, M.
Spiotto, M. T.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E819 - E819
[40] Induction chemotherapy followed by hyperfractionated radiotherapy with concurrent chemotherapy for locally advanced head and neck cancer
Karasawa, K
Shinoda, H
Katsui, K
Seki, K
Kohno, M
Hanyu, N
Nasu, S
Muramatsu, H
Maebayashi, K
Mitsuhashi, N
Yoshihara, T
ANTICANCER RESEARCH, 2003, 23 (6D) : 5031 - 5036

← 1 2 3 4 5 →